Evidence map›Paper›PMID 31149626›Full record

ArticleERJ open research2019

Amikacin exposure and susceptibility of macrolide-resistant

Shelby Daniel-Wayman, Shamira Shallom, Nabila Azeem, Kenneth N Olivier, Adrian M Zelazny, D Rebecca Prevots

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ERJ open research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Drug susceptibility profiles ofJournal of medical microbiology · 2025
    Article
  4. Journal of clinical tuberculosis and other mycobacterial diseases · 2023
    Article
  5. Inducible Resistance to Amikacin inInfection and drug resistance · 2022
    Article
  6. Review
  7. Etamycin as a NovelInternational journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Shelby Daniel-WaymanEpidemiology Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Shamira ShallomDept of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
Nabila AzeemDept of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
Kenneth N OlivierLaboratory of Chronic Airway Infection, Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Adrian M ZelaznyDept of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
D Rebecca PrevotsEpidemiology Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
National Institutes of Health Clinical Center · USNational Institutes of Health · USNational Institute of Allergy and Infectious Diseases · US

Funding

Bronchiectasis and chronic airway infectionZIAHL006200 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI FENNELLY, KEVIN · 2015 to 2025
$25.1M
Epidemiology of Mycobacterial InfectionsZIAAI001035 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI PREVOTS, D. REBECCA · 2009 to 2025
$11.6M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID31149626
PMCPMC6536947
OpenAlexW2946870086

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.